RETeval Study for Diabetic Retinopathy

NCT01950663 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

468

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Retinopathy

Interventions

DEVICE: RETeval

Sponsor

Inoveon Corporation

Collaborators

[object Object]
[object Object]